[ { "id": "econ-total-us-2026", "topic": "total_cost_of_care", "metric": "Total annual payments for health care, long-term care and hospice for people age 65+ with Alzheimer's or other dementias (all payers, excludes unpaid care)", "value": 409, "unit": "billion USD (2026 dollars)", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15, Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model projection for 2026). Does not include value of informal caregiving. Journal citation: Alzheimers Dement 2026;22, doi:10.1002/alz.71345." }, { "id": "econ-total-us-medicare-2026", "topic": "payer_share", "metric": "Medicare payments for people age 65+ with Alzheimer's or other dementias", "value": 186, "unit": "billion USD (2026 dollars)", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED. 45% of $409B total. Medicare + Medicaid together = $263B (64%)." }, { "id": "econ-total-us-medicare-share-2026", "topic": "payer_share", "metric": "Medicare share of total payments for people with Alzheimer's or other dementias", "value": 45, "unit": "percent", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model)." }, { "id": "econ-total-us-medicaid-2026", "topic": "payer_share", "metric": "Medicaid payments for people age 65+ with Alzheimer's or other dementias", "value": 77, "unit": "billion USD (2026 dollars)", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED. 19% of $409B total." }, { "id": "econ-total-us-medicaid-share-2026", "topic": "payer_share", "metric": "Medicaid share of total payments for people with Alzheimer's or other dementias", "value": 19, "unit": "percent", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model)." }, { "id": "econ-total-us-oop-2026", "topic": "out_of_pocket", "metric": "Out-of-pocket payments for people age 65+ with Alzheimer's or other dementias", "value": 103, "unit": "billion USD (2026 dollars)", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED. 25% of $409B total." }, { "id": "econ-total-us-oop-share-2026", "topic": "out_of_pocket", "metric": "Out-of-pocket share of total payments for people with Alzheimer's or other dementias", "value": 25, "unit": "percent", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model)." }, { "id": "econ-total-us-other-2026", "topic": "payer_share", "metric": "Other payer (private insurance, HMOs, other managed care, uncompensated care) payments for people age 65+ with Alzheimer's or other dementias", "value": 44, "unit": "billion USD (2026 dollars)", "year": 2026, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Figure 15)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED. 11% of $409B total." }, { "id": "econ-proj-us-2050", "topic": "cost_projection", "metric": "Projected total annual payments for health care and long-term care for people with Alzheimer's or other dementias in 2050", "value": 1000, "unit": "billion USD (2026 dollars)", "year": 2050, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures ('Looking to the Future')", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model). Source wording: 'just under $1 trillion in 2050 (in 2026 dollars)', from $409B in 2026; value recorded as the stated ceiling. Excludes effect of approved anti-amyloid drugs. Projection includes 2.4-fold increases in Medicare/Medicaid spending and in out-of-pocket expenses." }, { "id": "econ-proj-us-2050-growth-factor", "topic": "cost_projection", "metric": "Projected fold-increase in Medicare/Medicaid spending and in out-of-pocket expenses for dementia, 2026 to 2050", "value": 2.4, "unit": "fold", "year": 2050, "geography": "US-national", "population": "Americans age 65+ with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures ('Looking to the Future')", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED/PROJECTED (Lewin Model), 2026 dollars." }, { "id": "econ-unpaid-value-us-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid care provided by family and other unpaid caregivers of people with Alzheimer's or other dementias", "value": 446.3, "unit": "billion USD (2025 dollars)", "year": 2025, "geography": "US-national", "population": "12.7 million unpaid dementia caregivers", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Caregiving section, Table 10)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED estimate: 19.6 billion hours valued at the average of the state minimum wage and the median hourly cost of a home health aide (source calls this conservative). Appendix gives $446.312 billion." }, { "id": "econ-unpaid-hours-us-2025", "topic": "unpaid_caregiving", "metric": "Hours of unpaid care provided to people with Alzheimer's or other dementias", "value": 19.6, "unit": "billion hours", "year": 2025, "geography": "US-national", "population": "12.7 million unpaid dementia caregivers", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Caregiving section)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED from BRFSS caregiver survey data; appendix gives 19.608 billion hours. Average nearly 30 hours/week or 1,543 hours/year per caregiver." }, { "id": "econ-unpaid-hours-per-caregiver-2025", "topic": "unpaid_caregiving", "metric": "Average annual hours of unpaid care per dementia caregiver", "value": 1543, "unit": "hours per caregiver per year", "year": 2025, "geography": "US-national", "population": "unpaid dementia caregivers", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Caregiving section)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (survey-based estimate)." }, { "id": "econ-perperson-mcbs-all-2018", "topic": "per_person_cost", "metric": "Average annual per-person payments from all sources for health care and long-term care, traditional Medicare beneficiaries age 65+ WITH Alzheimer's or other dementias", "value": 46141, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional (fee-for-service) Medicare beneficiaries age 65+ with dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16; unpublished Medicare Current Beneficiary Survey 2018 data)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (survey + claims, 2018 utilization) inflated to 2025 dollars. Unadjusted for age/sex. Comparison group without dementia: $15,499. Includes community-dwelling and residential-care beneficiaries." }, { "id": "econ-perperson-mcbs-all-nodementia-2018", "topic": "per_person_cost", "metric": "Average annual per-person payments from all sources, traditional Medicare beneficiaries age 65+ WITHOUT Alzheimer's or other dementias", "value": 15499, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ without dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) inflated to 2025 dollars; comparison row for econ-perperson-mcbs-all-2018." }, { "id": "econ-perperson-mcbs-medicare-2018", "topic": "per_person_cost", "metric": "Average annual per-person Medicare payments, traditional Medicare beneficiaries age 65+ with Alzheimer's or other dementias", "value": 23231, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ with dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) in 2025 dollars. Without dementia: $8,371." }, { "id": "econ-perperson-mcbs-medicaid-2018", "topic": "per_person_cost", "metric": "Average annual per-person Medicaid payments, traditional Medicare beneficiaries age 65+ with Alzheimer's or other dementias", "value": 7158, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ with dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) in 2025 dollars. Without dementia: $322." }, { "id": "econ-perperson-mcbs-oop-2018", "topic": "out_of_pocket", "metric": "Average annual per-person out-of-pocket payments, traditional Medicare beneficiaries age 65+ with Alzheimer's or other dementias", "value": 10877, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ with dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) in 2025 dollars. Includes Medicare/other-insurance deductibles, copays, premiums and uncovered services. Without dementia: $2,674." }, { "id": "econ-perperson-mcbs-oop-nodementia-2018", "topic": "out_of_pocket", "metric": "Average annual per-person out-of-pocket payments, traditional Medicare beneficiaries age 65+ WITHOUT dementia", "value": 2674, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ without dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) in 2025 dollars; comparison row." }, { "id": "econ-perperson-mcbs-private-2018", "topic": "per_person_cost", "metric": "Average annual per-person private insurance payments, traditional Medicare beneficiaries age 65+ with dementia", "value": 1622, "unit": "USD per person per year (2025 dollars)", "year": 2018, "geography": "US-national", "population": "traditional Medicare beneficiaries age 65+ with dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Table 16)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (MCBS 2018) in 2025 dollars. HMO $2,063; uncompensated $203; other payer $987 for the dementia group." }, { "id": "econ-oop-share-income-2026ff", "topic": "out_of_pocket", "metric": "Share of annual (individual plus spouse/partner) income spent on out-of-pocket health care by people with Alzheimer's dementia, excluding nursing home and informal care", "value": 12, "unit": "percent of income", "year": 2026, "geography": "US-national", "population": "people with Alzheimer's dementia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Use and Costs section, citing ref. 920)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (survey-based study cited by Facts and Figures; underlying study year not stated in the passage). Comparison: 7% for people without Alzheimer's dementia. Year field is publication year of the compendium." }, { "id": "econ-oop-median-2023", "topic": "out_of_pocket", "metric": "Median annual out-of-pocket health care cost among people with moderate or severe dementia who had any expenditures", "value": 2853, "unit": "USD (2023 dollars)", "year": 2023, "geography": "US-national", "population": "people with moderate or severe dementia with any OOP expenditure", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Use and Costs section, citing ref. 921)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED. $3,010 in 2025 dollars. 71% of moderate and 80% of severe dementia had OOP costs in prior year; 21% of severe dementia had OOP costs >40% of post-subsistence income; 12% fell below federal poverty level after OOP costs." }, { "id": "econ-oop-nursinghome-severe-2023", "topic": "out_of_pocket", "metric": "Median annual out-of-pocket nursing home expenditure among the 31% of people with severe dementia who incurred nursing home expenditures", "value": 4118, "unit": "USD (2023 dollars)", "year": 2023, "geography": "US-national", "population": "people with severe dementia with nursing home expenditures", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (Use and Costs section, citing ref. 921)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED. $4,345 in 2025 dollars. Moderate dementia with nursing home expenditures: median $40,165 ($42,378 in 2025 dollars)." }, { "id": "econ-oop-trajectory-y1-2-2017", "topic": "out_of_pocket", "metric": "Annual out-of-pocket costs in the first two years after dementia diagnosis", "value": 3104, "unit": "USD (2017 dollars)", "year": 2017, "geography": "US-national", "population": "people with Alzheimer's or other dementias", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures (citing ref. 918)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED. Rises to $3,730 in years 3-4 and $3,934 in years 7-8 after diagnosis (2017 dollars; $3,783 / $4,546 / $4,795 in 2025 dollars)." }, { "id": "econ-lifetime-cost-jutkowitz-2015", "topic": "per_person_cost", "metric": "Discounted lifetime total cost of care per person with dementia from diagnosis (mean age 83) to death, including informal care, out-of-pocket, Medicaid and Medicare", "value": 321780, "unit": "USD (2015 dollars)", "year": 2015, "geography": "US-national", "population": "simulated representative US incident dementia cases", "source_name": "Jutkowitz E et al. Societal and Family Lifetime Cost of Dementia. J Am Geriatr Soc 2017; doi:10.1111/jgs.15043 (PMID 28815557)", "source_url": "https://doi.org/10.1111/jgs.15043", "notes": "MODELLED (microsimulation). Families incurred 70% ($225,140), Medicaid 14% ($44,090), Medicare 16% ($52,540). Incremental cost vs no dementia $184,500 (86% borne by families). Annual cost peaked at $89,000. Facts and Figures 2026 restates as $417,263 in 2025 dollars." }, { "id": "econ-lifetime-cost-family-share", "topic": "unpaid_caregiving", "metric": "Share of lifetime dementia cost of care borne by families (unpaid caregiving plus out-of-pocket)", "value": 70, "unit": "percent", "year": 2015, "geography": "US-national", "population": "simulated representative US incident dementia cases", "source_name": "Jutkowitz E et al. J Am Geriatr Soc 2017 (PMID 28815557)", "source_url": "https://doi.org/10.1111/jgs.15043", "notes": "MODELLED. Families $225,140 of $321,780 lifetime cost (2015 dollars)." }, { "id": "econ-annual-peak-jutkowitz", "topic": "per_person_cost", "metric": "Peak total annual cost of care per person with dementia (all payers incl. informal care)", "value": 89000, "unit": "USD per year (2015 dollars)", "year": 2015, "geography": "US-national", "population": "simulated representative US incident dementia cases", "source_name": "Jutkowitz E et al. J Am Geriatr Soc 2017 (PMID 28815557)", "source_url": "https://doi.org/10.1111/jgs.15043", "notes": "MODELLED. Net (incremental) annual cost peaked at $72,400." }, { "id": "econ-incremental-hurd-2010-formal", "topic": "per_person_cost", "metric": "Yearly monetary cost per person attributable to dementia, informal care valued at cost of equivalent formal care", "value": 56290, "unit": "USD per person per year (2010 dollars)", "year": 2010, "geography": "US-national", "population": "US adults >70 with dementia (Health and Retirement Study / ADAMS)", "source_name": "Hurd MD et al. Monetary costs of dementia in the United States. N Engl J Med 2013; doi:10.1056/NEJMsa1204629 (PMID 23550670)", "source_url": "https://doi.org/10.1056/NEJMsa1204629", "notes": "MEASURED (survey + Medicare claims), with dementia status estimated statistically for most of the sample. 95% CI $42,746-$69,834. Alternative valuation (forgone wages): $41,689 (95% CI $31,017-$52,362). Total US cost 2010: $157B-$215B; Medicare paid ~$11B." }, { "id": "econ-incremental-hurd-2010-total", "topic": "total_cost_of_care", "metric": "Total monetary cost of dementia in the US in 2010 (upper bound, informal care valued at replacement cost)", "value": 215, "unit": "billion USD (2010 dollars)", "year": 2010, "geography": "US-national", "population": "US adults >70 with dementia", "source_name": "Hurd MD et al. N Engl J Med 2013 (PMID 23550670)", "source_url": "https://doi.org/10.1056/NEJMsa1204629", "notes": "MEASURED-BASED estimate; lower bound $157B (forgone-wages valuation). Historical comparator for the Facts and Figures $409B (2026) figure; different methods (attributable vs all-cause costs)." }, { "id": "econ-incremental-annual-hurd-ff", "topic": "per_person_cost", "metric": "Annual incremental health care and nursing home cost per person attributable to dementia (excluding informal care)", "value": 28501, "unit": "USD per person per year (2010 dollars)", "year": 2010, "geography": "US-national", "population": "US adults >70 with dementia", "source_name": "Alzheimer's Association, 2026 Facts and Figures, citing Hurd et al. 2013", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED-BASED. $42,509 in 2025 dollars per Facts and Figures." }, { "id": "econ-medicare-5yr-incremental-white-2019", "topic": "per_person_cost", "metric": "Five-year incremental cost of dementia to the traditional Medicare program per patient after claims-based diagnosis", "value": 15700, "unit": "USD per patient over 5 years", "year": 2017, "geography": "US-national", "population": "HRS-linked traditional Medicare beneficiaries with claims-based dementia diagnosis, 1991-2012", "source_name": "White L et al. Medicare expenditures attributable to dementia. Health Serv Res 2019; doi:10.1111/1475-6773.13134 (PMID 30868557)", "source_url": "https://doi.org/10.1111/1475-6773.13134", "notes": "MEASURED (claims, matched comparison). Nearly half incurred in first year after diagnosis. Dollar year is 2017 per Facts and Figures 2026 restatement ($19,501 in 2025 dollars); abstract does not state dollar year explicitly." }, { "id": "econ-medicare-dx-spike-hoffman-2022", "topic": "per_person_cost", "metric": "Adjusted quarterly Medicare spending in the quarter including a clinical dementia diagnosis", "value": 13794, "unit": "USD per quarter", "year": 2018, "geography": "US-national", "population": "HRS-linked Medicare beneficiaries age 65+ with new dementia diagnosis (n=2,779), 1998-2018", "source_name": "Hoffman GJ et al. Medicare spending associated with a dementia diagnosis among older adults. J Am Geriatr Soc 2022; doi:10.1111/jgs.17835 (PMID 35583388)", "source_url": "https://doi.org/10.1111/jgs.17835", "notes": "MEASURED (claims). Up from $5,394 in the prior quarter (+$8,400, +156%). Year field = end of study period; dollar year not stated in abstract." }, { "id": "econ-stage-leibson-cn", "topic": "per_person_cost_by_stage", "metric": "Annual mean direct medical cost, cognitively normal (excludes long-term care and indirect costs)", "value": 6042, "unit": "USD per person per year", "year": 2015, "geography": "US-national", "population": "Olmsted County MN residents age 70-89 (Mayo Clinic Study of Aging)", "source_name": "Leibson CL et al. Direct medical costs and source of cost differences across the spectrum of cognitive decline. Alzheimers Dement 2015; doi:10.1016/j.jalz.2015.01.007 (PMID 25858682)", "source_url": "https://doi.org/10.1016/j.jalz.2015.01.007", "notes": "MEASURED (provider-linked administrative cost data, one year pre-index). Single-county population; dollar year not stated in abstract (publication 2015)." }, { "id": "econ-stage-leibson-mci", "topic": "per_person_cost_by_stage", "metric": "Annual mean direct medical cost, mild cognitive impairment (excludes long-term care and indirect costs)", "value": 6784, "unit": "USD per person per year", "year": 2015, "geography": "US-national", "population": "Olmsted County MN residents age 70-89 (Mayo Clinic Study of Aging)", "source_name": "Leibson CL et al. Alzheimers Dement 2015 (PMID 25858682)", "source_url": "https://doi.org/10.1016/j.jalz.2015.01.007", "notes": "MEASURED. Difference from cognitively normal not statistically significant." }, { "id": "econ-stage-leibson-newdementia", "topic": "per_person_cost_by_stage", "metric": "Annual mean direct medical cost, newly discovered dementia (excludes long-term care and indirect costs)", "value": 9431, "unit": "USD per person per year", "year": 2015, "geography": "US-national", "population": "Olmsted County MN residents age 70-89 (Mayo Clinic Study of Aging)", "source_name": "Leibson CL et al. Alzheimers Dement 2015 (PMID 25858682)", "source_url": "https://doi.org/10.1016/j.jalz.2015.01.007", "notes": "MEASURED." }, { "id": "econ-stage-leibson-prevdementia", "topic": "per_person_cost_by_stage", "metric": "Annual mean direct medical cost, prevalent (established) dementia (excludes long-term care and indirect costs)", "value": 11678, "unit": "USD per person per year", "year": 2015, "geography": "US-national", "population": "Olmsted County MN residents age 70-89 (Mayo Clinic Study of Aging)", "source_name": "Leibson CL et al. Alzheimers Dement 2015 (PMID 25858682)", "source_url": "https://doi.org/10.1016/j.jalz.2015.01.007", "notes": "MEASURED. Hospital inpatient costs were 70% of total for prevalent dementia." }, { "id": "econ-global-total-2019", "topic": "total_cost_of_care", "metric": "Annual global societal cost of dementia", "value": 1313.4, "unit": "billion USD (2019)", "year": 2019, "geography": "global", "population": "55.2 million people with dementia worldwide", "source_name": "Wimo A et al. The worldwide costs of dementia in 2019. Alzheimers Dement 2023; doi:10.1002/alz.12901 (PMID 36617519)", "source_url": "https://doi.org/10.1002/alz.12901", "notes": "MODELLED (global cost model built from country cost studies). Direct medical $213.2B (16%), direct social sector incl. long-term care $448.7B (34%), informal care $651.4B (50%). 74% of costs occur in high-income countries." }, { "id": "econ-global-perperson-2019", "topic": "per_person_cost", "metric": "Global average annual societal cost per person with dementia", "value": 23796, "unit": "USD per person per year (2019)", "year": 2019, "geography": "global", "population": "55.2 million people with dementia worldwide", "source_name": "Wimo A et al. Alzheimers Dement 2023 (PMID 36617519)", "source_url": "https://doi.org/10.1002/alz.12901", "notes": "MODELLED." }, { "id": "econ-global-informal-share-2019", "topic": "unpaid_caregiving", "metric": "Informal (unpaid) care share of global societal cost of dementia", "value": 50, "unit": "percent", "year": 2019, "geography": "global", "population": "people with dementia worldwide", "source_name": "Wimo A et al. Alzheimers Dement 2023 (PMID 36617519)", "source_url": "https://doi.org/10.1002/alz.12901", "notes": "MODELLED. Informal care valued at US$651.4 billion." }, { "id": "econ-global-total-2015", "topic": "total_cost_of_care", "metric": "Annual global societal cost of dementia (2015 estimate)", "value": 818, "unit": "billion USD (2015)", "year": 2015, "geography": "global", "population": "people with dementia worldwide", "source_name": "Wimo A et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 2017; doi:10.1016/j.jalz.2016.07.150 (PMID 27583652)", "source_url": "https://doi.org/10.1016/j.jalz.2016.07.150", "notes": "MODELLED. 35% increase since 2010; 86% of costs in high-income countries." }, { "id": "econ-lecanemab-wac-annual-2023", "topic": "drug_price_list", "metric": "Lecanemab (Leqembi) IV annual wholesale acquisition cost (list price) at US launch, 10 mg/kg biweekly, 75 kg patient", "value": 26500, "unit": "USD per patient per year", "year": 2023, "geography": "US-national", "population": "early Alzheimer's disease (MCI or mild dementia due to AD)", "source_name": "Eisai press release, 6 Jan 2023: Eisai's approach to U.S. pricing for LEQEMBI", "source_url": "https://media-us.eisai.com/2023-01-06-EISAIS-APPROACH-TO-U-S-PRICING-FOR-LEQEMBI-TM-LECANEMAB-,-A-TREATMENT-FOR-EARLY-ALZHEIMERS-DISEASE,-SETS-FORTH-OUR-CONCEPT-OF-SOCIETAL-VALUE-OF-MEDICINE-IN-RELATION-TO-PRICE-OF-MEDICINE", "notes": "LIST PRICE (WAC), manufacturer-announced. Vial WAC: 200 mg $254.81; 500 mg $637.02. Eisai's own modelled 'societal value' was $37,600/yr. Actual annualized price varies with body weight." }, { "id": "econ-lecanemab-wac-500mg-vial-2023", "topic": "drug_price_list", "metric": "Lecanemab 500 mg vial wholesale acquisition cost", "value": 637.02, "unit": "USD per vial", "year": 2023, "geography": "US-national", "population": "early Alzheimer's disease", "source_name": "Eisai press release, 6 Jan 2023", "source_url": "https://media-us.eisai.com/2023-01-06-EISAIS-APPROACH-TO-U-S-PRICING-FOR-LEQEMBI-TM-LECANEMAB-,-A-TREATMENT-FOR-EARLY-ALZHEIMERS-DISEASE,-SETS-FORTH-OUR-CONCEPT-OF-SOCIETAL-VALUE-OF-MEDICINE-IN-RELATION-TO-PRICE-OF-MEDICINE", "notes": "LIST PRICE. 200 mg vial $254.81. Implies about $1.274/mg." }, { "id": "econ-lecanemab-iqlik-wac-2026", "topic": "drug_price_list", "metric": "Lecanemab subcutaneous autoinjector (Leqembi Iqlik) wholesale acquisition cost per 250 mg autoinjector", "value": 385, "unit": "USD per autoinjector", "year": 2026, "geography": "US-national", "population": "early Alzheimer's disease (at-home subcutaneous initiation or maintenance)", "source_name": "Eisai statement: LEQEMBI IQLIK U.S. pricing and access", "source_url": "https://us.eisai.com/-/media/Files/USEisaiRedesign/Leqembi_iQLIK_Statement_Pricing.pdf", "notes": "LIST PRICE (WAC). Subcutaneous initiation dose requires two autoinjectors (500 mg per weekly dose). Eisai states WAC does not reflect what patients pay. Statement is undated in its text but cites the 2026 Facts and Figures 'accessed April 28, 2026', so it dates from 2026 (SC initiation-dose approval)." }, { "id": "econ-donanemab-wac-vial-2024", "topic": "drug_price_list", "metric": "Donanemab (Kisunla) wholesale acquisition cost per 350 mg vial", "value": 695.65, "unit": "USD per vial", "year": 2024, "geography": "US-national", "population": "early symptomatic Alzheimer's disease", "source_name": "Eli Lilly press release, 2 Jul 2024: Kisunla approved by the FDA", "source_url": "https://investor.lilly.com/news-releases/news-release-details/lillys-kisunlatm-donanemab-azbt-approved-fda-treatment-early", "notes": "LIST PRICE. Lilly states total cost varies with treatment duration because dosing can stop once amyloid is cleared on PET. Release's 'Course of Therapy Cost' table: 6 months $12,522; 12 months $32,000; 18 months $48,696." }, { "id": "econ-donanemab-wac-12mo-2024", "topic": "drug_price_list", "metric": "Donanemab (Kisunla) list-price cost of a 12-month course (13 monthly infusions)", "value": 32000, "unit": "USD per patient per 12 months", "year": 2024, "geography": "US-national", "population": "early symptomatic Alzheimer's disease", "source_name": "Eli Lilly press release, 2 Jul 2024 (cost table: 12-month treatment)", "source_url": "https://investor.lilly.com/news-releases/news-release-details/lillys-kisunlatm-donanemab-azbt-approved-fda-treatment-early", "notes": "LIST PRICE, manufacturer-stated: 13 vials-per-infusion schedule totals $32,000 for 12 months; 6-month course $12,522; 18-month course $48,696 per the release's table. Value here is the 12-month figure." }, { "id": "econ-lecanemab-cms-payment-limit-2026q4", "topic": "drug_price_net", "metric": "Medicare Part B payment allowance limit for lecanemab (HCPCS J0174), per 1 mg, effective 1 Oct-31 Dec 2026 (ASP-based)", "value": 1.361, "unit": "USD per mg", "year": 2026, "geography": "US-national", "population": "Medicare Part B beneficiaries", "source_name": "CMS October 2026 Medicare Part B Payment Limit File (based on 2Q26 ASP data)", "source_url": "https://www.cms.gov/files/zip/october-2026-medicare-part-b-payment-limit-files-final.zip", "notes": "NET-PRICE PROXY: payment limit = average sales price (net of manufacturer discounts/rebates to purchasers) plus statutory add-on. Coinsurance 20%. Compare WAC ~$1.274/mg (500 mg vial). Derived annual amount at 10 mg/kg biweekly for a 75 kg patient (19,500 mg/yr) would be about $26,540; that derivation is ours, not CMS's." }, { "id": "econ-donanemab-cms-payment-limit-2026q4", "topic": "drug_price_net", "metric": "Medicare Part B payment allowance limit for donanemab (HCPCS J0175), per 2 mg, effective 1 Oct-31 Dec 2026 (ASP-based)", "value": 4.185, "unit": "USD per 2 mg", "year": 2026, "geography": "US-national", "population": "Medicare Part B beneficiaries", "source_name": "CMS October 2026 Medicare Part B Payment Limit File (based on 2Q26 ASP data)", "source_url": "https://www.cms.gov/files/zip/october-2026-medicare-part-b-payment-limit-files-final.zip", "notes": "NET-PRICE PROXY (ASP-based). Equals $2.0925/mg, i.e. about $732 per 350 mg vial versus WAC $695.65 (ASP-based limit includes the statutory add-on percentage). Coinsurance 20%." }, { "id": "econ-lecanemab-medicare-allowed-per-mg-2024", "topic": "drug_price_net", "metric": "Average Medicare allowed amount per 1 mg lecanemab (J0174), physician/supplier claims, national, 2024", "value": 1.305, "unit": "USD per mg", "year": 2024, "geography": "US-national", "population": "Medicare fee-for-service beneficiaries receiving lecanemab in office/non-facility settings", "source_name": "CMS Medicare Physician & Other Practitioners - by Geography and Service, 2024", "source_url": "https://data.cms.gov/data-api/v1/dataset/6fea9d79-0129-4e4c-b1b8-23cd86a4f435/data?filter[HCPCS_Cd]=J0174&filter[Rndrng_Prvdr_Geo_Lvl]=National", "notes": "MEASURED (claims). Avg_Mdcr_Alowd_Amt 1.3049; Avg_Mdcr_Pymt_Amt 1.0383 (Medicare's ~80% share; remainder is beneficiary coinsurance). 4,734 beneficiaries and 41.7 million mg in this dataset (excludes hospital outpatient department claims, so not total uptake)." }, { "id": "econ-lecanemab-medicare-benes-physician-2024", "topic": "uptake", "metric": "Number of Medicare FFS beneficiaries with lecanemab (J0174) physician/supplier claims, national, 2024", "value": 4734, "unit": "beneficiaries", "year": 2024, "geography": "US-national", "population": "Medicare fee-for-service beneficiaries", "source_name": "CMS Medicare Physician & Other Practitioners - by Geography and Service, 2024", "source_url": "https://data.cms.gov/data-api/v1/dataset/6fea9d79-0129-4e4c-b1b8-23cd86a4f435/data?filter[HCPCS_Cd]=J0174&filter[Rndrng_Prvdr_Geo_Lvl]=National", "notes": "MEASURED (claims). Partial: physician/supplier (Part B professional) claims only; hospital outpatient infusions are in a separate dataset and not included. Donanemab (J0175): 1,142 beneficiaries in the same file." }, { "id": "econ-donanemab-medicare-allowed-per-2mg-2024", "topic": "drug_price_net", "metric": "Average Medicare allowed amount per 2 mg donanemab (J0175), physician/supplier claims, national, 2024", "value": 4.162, "unit": "USD per 2 mg", "year": 2024, "geography": "US-national", "population": "Medicare fee-for-service beneficiaries receiving donanemab in office/non-facility settings", "source_name": "CMS Medicare Physician & Other Practitioners - by Geography and Service, 2024", "source_url": "https://data.cms.gov/data-api/v1/dataset/6fea9d79-0129-4e4c-b1b8-23cd86a4f435/data?filter[HCPCS_Cd]=J0175&filter[Rndrng_Prvdr_Geo_Lvl]=National", "notes": "MEASURED (claims). Avg_Mdcr_Alowd_Amt 4.1615; Avg_Mdcr_Pymt_Amt 3.3157. 1,142 beneficiaries; 978,159 units of 2 mg." }, { "id": "econ-infusion-96413-medicare-allowed-2024", "topic": "infusion_monitoring_cost", "metric": "Average Medicare allowed amount for IV infusion administration, first hour (CPT 96413), office setting, national, 2024", "value": 125.21, "unit": "USD per infusion", "year": 2024, "geography": "US-national", "population": "Medicare fee-for-service beneficiaries (all indications; code is used for lecanemab/donanemab infusions)", "source_name": "CMS Medicare Physician & Other Practitioners - by Geography and Service, 2024", "source_url": "https://data.cms.gov/data-api/v1/dataset/6fea9d79-0129-4e4c-b1b8-23cd86a4f435/data?filter[HCPCS_Cd]=96413&filter[Rndrng_Prvdr_Geo_Lvl]=National", "notes": "MEASURED (claims, all indications, not dementia-specific). Medicare payment $98.25 (80%); beneficiary/supplemental coinsurance 20%. Each additional hour (96415): allowed $26.90." }, { "id": "econ-mri-70551-medicare-allowed-2024", "topic": "infusion_monitoring_cost", "metric": "Average Medicare allowed amount for MRI brain without contrast (CPT 70551), office/global setting, national, 2024", "value": 155.06, "unit": "USD per scan", "year": 2024, "geography": "US-national", "population": "Medicare fee-for-service beneficiaries (all indications; ARIA monitoring scans use this code)", "source_name": "CMS Medicare Physician & Other Practitioners - by Geography and Service, 2024", "source_url": "https://data.cms.gov/data-api/v1/dataset/6fea9d79-0129-4e4c-b1b8-23cd86a4f435/data?filter[HCPCS_Cd]=70551&filter[Rndrng_Prvdr_Geo_Lvl]=National", "notes": "MEASURED (claims, all indications). Facility (professional component only) allowed $68.28. Medicare pays 80%." }, { "id": "econ-medicare-partb-coinsurance", "topic": "who_pays", "metric": "Medicare Part B beneficiary coinsurance for lecanemab and donanemab (Part B drugs) and their infusion/monitoring services", "value": 20, "unit": "percent of Medicare-approved amount", "year": 2026, "geography": "US-national", "population": "Original Medicare beneficiaries", "source_name": "CMS October 2026 Medicare Part B Payment Limit File (Co-insurance Percentage column) and Medicare.gov Medicare costs", "source_url": "https://www.medicare.gov/basics/costs/medicare-costs", "notes": "MEASURED/STATUTORY. Coinsurance paid out-of-pocket unless covered by Medigap, Medicaid (dual eligibles) or a Medicare Advantage plan's cost-sharing rules. 2026 Part B deductible $283; standard Part B premium $202.90/month (Medicare.gov)." }, { "id": "econ-medicare-partb-deductible-2026", "topic": "who_pays", "metric": "Medicare Part B annual deductible", "value": 283, "unit": "USD per year", "year": 2026, "geography": "US-national", "population": "Original Medicare beneficiaries", "source_name": "Medicare.gov, Medicare costs (2026)", "source_url": "https://www.medicare.gov/basics/costs/medicare-costs", "notes": "MEASURED/STATUTORY. Standard Part B premium 2026: $202.90/month." }, { "id": "econ-arbanas-drug-cost-per-patient", "topic": "infusion_monitoring_cost", "metric": "Modelled total annualized weight-based lecanemab medication cost per Medicare beneficiary", "value": 25851, "unit": "USD per patient per year (2023 WAC basis)", "year": 2023, "geography": "US-national", "population": "Medicare beneficiaries age 65+ with MCI or mild dementia (HRS 2018 weights)", "source_name": "Arbanas JC et al. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med 2023; doi:10.1001/jamainternmed.2023.1749 (PMID 37167598)", "source_url": "https://doi.org/10.1001/jamainternmed.2023.1749", "notes": "MODELLED from 2018 HRS body weights and WAC vial prices, 24 infusions/yr. Medicare 80% share $20,680.55; beneficiary coinsurance $5,170.14." }, { "id": "econ-arbanas-ancillary-cost-per-patient", "topic": "infusion_monitoring_cost", "metric": "Modelled annual ancillary costs of lecanemab treatment per Medicare beneficiary (PET, infusions, MRI, visits, APOE test, ARIA care)", "value": 7330, "unit": "USD per patient per year (2022 Medicare fee schedule)", "year": 2023, "geography": "US-national", "population": "Medicare beneficiaries age 65+ with MCI or mild dementia", "source_name": "Arbanas JC et al. JAMA Intern Med 2023 (PMID 37167598)", "source_url": "https://doi.org/10.1001/jamainternmed.2023.1749", "notes": "MODELLED. Components (Medicare-approved unit cost x events/yr): amyloid PET 1 x $1,564.88; IV infusion 24 x $133.67; neurology/geriatrics visits 4 x $155.75; routine brain MRI 3 x $445.01; APOE test 1 x $99; ARIA-related extra MRI 0.172/yr; ARIA-related visits 0.172/yr; hospitalization for severe AE 0.027 x $14,700. Ancillary costs raise per-patient total by 28%." }, { "id": "econ-arbanas-coinsurance-per-patient", "topic": "who_pays", "metric": "Modelled maximum annual per-patient coinsurance (20% of drug + ancillary) for lecanemab, Medicare beneficiary without supplemental coverage", "value": 6636, "unit": "USD per patient per year", "year": 2023, "geography": "US-national", "population": "Original Medicare beneficiaries without Medigap/Medicaid", "source_name": "Arbanas JC et al. JAMA Intern Med 2023 (PMID 37167598)", "source_url": "https://doi.org/10.1001/jamainternmed.2023.1749", "notes": "MODELLED ($6,636.18). Range $0 (dual-eligible Medicaid pays or Medigap covers) to $6,636. Total per-patient cost incl. coinsurance $26,544.72 + ancillary." }, { "id": "econ-arbanas-medicare-spend-lower", "topic": "budget_impact", "metric": "Modelled annual Medicare spending on lecanemab plus ancillary services, lower-bound uptake (85,687 patients)", "value": 2.0, "unit": "billion USD per year", "year": 2023, "geography": "US-national", "population": "Medicare beneficiaries with MCI or mild dementia due to AD", "source_name": "Arbanas JC et al. JAMA Intern Med 2023 (PMID 37167598)", "source_url": "https://doi.org/10.1001/jamainternmed.2023.1749", "notes": "MODELLED. 95% CI $1.8-2.2B. Upper bound (216,536 patients): $5.1B (95% CI $4.6-5.7B). Assumes 19% attrition; excludes rebates." }, { "id": "econ-arbanas-medicare-spend-upper", "topic": "budget_impact", "metric": "Modelled annual Medicare spending on lecanemab plus ancillary services, upper-bound uptake (216,536 patients)", "value": 5.1, "unit": "billion USD per year", "year": 2023, "geography": "US-national", "population": "Medicare beneficiaries with MCI or mild dementia due to AD", "source_name": "Arbanas JC et al. JAMA Intern Med 2023 (PMID 37167598)", "source_url": "https://doi.org/10.1001/jamainternmed.2023.1749", "notes": "MODELLED. 95% CI $4.6-5.7B." }, { "id": "econ-zhou-lecanemab-waste-per-patient", "topic": "infusion_monitoring_cost", "metric": "Modelled cost of discarded (wasted) lecanemab per patient per year due to vial sizes and weight-based dosing", "value": 1619, "unit": "USD per patient per year", "year": 2024, "geography": "US-national", "population": "Medicare-eligible adults with MCI or mild dementia (HRS)", "source_name": "Zhou FF et al. Reducing Wasteful Spending on Discarded Lecanemab in the US Medicare Program. JAMA Intern Med 2024; doi:10.1001/jamainternmed.2024.5292 (PMID 39401006)", "source_url": "https://doi.org/10.1001/jamainternmed.2024.5292", "notes": "MODELLED. 5.8% of dispensed drug wasted (1.6 doses/yr). Total annual Medicare waste $133M-$336M at 1.1%-2.9% uptake. Per-unit cost assumed $1.31/mg (WAC + 3%)." }, { "id": "econ-icer-lecanemab-hcs-qaly-2023", "topic": "cost_effectiveness", "metric": "ICER base-case incremental cost-effectiveness ratio, lecanemab + supportive care vs supportive care, health care sector perspective", "value": 254000, "unit": "USD per QALY gained", "year": 2023, "geography": "US-national", "population": "MCI due to AD or mild AD dementia", "source_name": "Institute for Clinical and Economic Review, Lecanemab for Early Alzheimer's Disease: Final Evidence Report, 17 Apr 2023 (Table 4.5)", "source_url": "https://icer.org/wp-content/uploads/2023/04/ICER_Alzheimers-Disease_Final-Report_For-Publication_04172023.pdf", "notes": "MODELLED (Markov model, lifetime horizon, WAC $26,500/yr). Judged against ICER's $100,000-$150,000 per QALY thresholds: NOT cost-effective. Cost per life-year $277,000; per evLY $204,000. Peer-reviewed summary: Wright AC et al. J Manag Care Spec Pharm 2023 (PMID 37610113)." }, { "id": "econ-icer-lecanemab-societal-qaly-2023", "topic": "cost_effectiveness", "metric": "ICER base-case incremental cost-effectiveness ratio, lecanemab vs supportive care, modified societal perspective", "value": 236000, "unit": "USD per QALY gained", "year": 2023, "geography": "US-national", "population": "MCI due to AD or mild AD dementia", "source_name": "ICER Final Evidence Report, 17 Apr 2023 (Table 4.5)", "source_url": "https://icer.org/wp-content/uploads/2023/04/ICER_Alzheimers-Disease_Final-Report_For-Publication_04172023.pdf", "notes": "MODELLED. Threshold $100,000-$150,000/QALY: NOT cost-effective. Per evLY $183,000. If treatment continued until severe AD: $286,000/QALY (health care sector)." }, { "id": "econ-icer-lecanemab-hbpb-low-2023", "topic": "cost_effectiveness", "metric": "ICER health-benefit price benchmark for lecanemab, lower bound (annual price achieving $100,000 per QALY, health care sector)", "value": 8900, "unit": "USD per year", "year": 2023, "geography": "US-national", "population": "MCI due to AD or mild AD dementia", "source_name": "ICER Final Evidence Report, 17 Apr 2023 (Tables 4.9, 6.1)", "source_url": "https://icer.org/wp-content/uploads/2023/04/ICER_Alzheimers-Disease_Final-Report_For-Publication_04172023.pdf", "notes": "MODELLED threshold price. Full HBPB range $8,900-$21,500 (19%-66% discount from $26,500 WAC). Price to reach $150,000/QALY (health care sector) $14,600; $50,000/QALY $3,200; $200,000/QALY $20,300. Excludes 6% provider markup." }, { "id": "econ-icer-lecanemab-hbpb-high-2023", "topic": "cost_effectiveness", "metric": "ICER health-benefit price benchmark for lecanemab, upper bound (annual price achieving $150,000 per evLY gained, societal perspective)", "value": 21500, "unit": "USD per year", "year": 2023, "geography": "US-national", "population": "MCI due to AD or mild AD dementia", "source_name": "ICER Final Evidence Report, 17 Apr 2023 (Table 6.1)", "source_url": "https://icer.org/wp-content/uploads/2023/04/ICER_Alzheimers-Disease_Final-Report_For-Publication_04172023.pdf", "notes": "MODELLED threshold price; 19% discount from WAC." }, { "id": "econ-icer-lecanemab-budget-share-2023", "topic": "budget_impact", "metric": "Share of the estimated 1.4 million eligible US patients who could be treated with lecanemab at WAC without exceeding ICER's $777M/yr budget-impact threshold", "value": 5, "unit": "percent of eligible population", "year": 2023, "geography": "US-national", "population": "US patients with MCI due to AD or mild AD (1.4 million eligible; 280,000/yr assumed to initiate)", "source_name": "ICER Final Evidence Report, 17 Apr 2023 (Section 7)", "source_url": "https://icer.org/wp-content/uploads/2023/04/ICER_Alzheimers-Disease_Final-Report_For-Publication_04172023.pdf", "notes": "MODELLED. Cumulative per-patient net budget impact ~$27,000 in year 1, ~$104,000 over 5 years at WAC. 9% treatable at $150k/QALY price, 16% at $100k, 59% at $50k." }, { "id": "econ-nguyen-lecanemab-threshold-price-2024", "topic": "cost_effectiveness", "metric": "Annual lecanemab price below which CSF-test-then-targeted-treatment strategy becomes cost-effective (independent model)", "value": 5100, "unit": "USD per year", "year": 2024, "geography": "US-national", "population": "MCI or mild dementia due to AD", "source_name": "Nguyen HV, Mital S, Knopman DS, Alexander GC. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease. Neurology 2024; doi:10.1212/WNL.0000000000209218 (PMID 38484190)", "source_url": "https://doi.org/10.1212/WNL.0000000000209218", "notes": "MODELLED (hybrid decision tree-Markov, lifetime, 2022 USD). Conclusion: neither targeted nor unrestricted lecanemab was cost-effective vs standard of care at current price; standard of care alone was optimal. Base-case ICER value is in the full text, which was paywalled; not recorded here. Willingness-to-pay threshold used is stated in the full text (not in abstract)." }, { "id": "econ-ross-donanemab-icer-hcs-2022", "topic": "cost_effectiveness", "metric": "Independent model ICER for donanemab vs standard care, health care sector perspective (pre-approval, phase 2 efficacy, assumed $28,000/yr price)", "value": 193000, "unit": "USD per QALY gained (2020 USD)", "year": 2022, "geography": "US-national", "population": "early AD (65% MCI, 35% mild dementia), mean age 75", "source_name": "Ross EL, Weinberg MS, Arnold SE. Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US. JAMA Neurol 2022; doi:10.1001/jamaneurol.2022.0315 (PMID 35344024)", "source_url": "https://doi.org/10.1001/jamaneurol.2022.0315", "notes": "MODELLED. Willingness-to-pay threshold $150,000/QALY: NOT cost-effective. Societal ICER $176,000/QALY. QALY gain 0.408; drug cost $44,600 (dosing stops after amyloid clearance)." }, { "id": "econ-ross-aducanumab-icer-hcs-2022", "topic": "cost_effectiveness", "metric": "Independent model ICER for aducanumab vs standard care, health care sector perspective ($28,000/yr price)", "value": 981000, "unit": "USD per QALY gained (2020 USD)", "year": 2022, "geography": "US-national", "population": "early AD", "source_name": "Ross EL et al. JAMA Neurol 2022 (PMID 35344024)", "source_url": "https://doi.org/10.1001/jamaneurol.2022.0315", "notes": "MODELLED. Threshold $150,000/QALY: NOT cost-effective. Societal $964,000/QALY. Value-based price stayed below $50,000/yr even at 90% efficacy." }, { "id": "econ-icer-aducanumab-qaly-2022", "topic": "cost_effectiveness", "metric": "ICER cost per QALY for aducanumab at $56,000/yr launch price, health care sector perspective (pooled trial efficacy)", "value": 1330000, "unit": "USD per QALY gained", "year": 2022, "geography": "US-national", "population": "early AD", "source_name": "Whittington MD et al. Cost-Effectiveness and Value-Based Pricing of Aducanumab. Neurology 2022; doi:10.1212/WNL.0000000000013314 (PMID 35022306)", "source_url": "https://doi.org/10.1212/WNL.0000000000013314", "notes": "MODELLED. Range $1.02M per evLYG to $1.33M per QALY. Threshold prices $2,950-$8,360/yr (85-95% discount). Judged against $100,000-$150,000/QALY thresholds: NOT cost-effective." }, { "id": "econ-lilly-donanemab-ejp-150k", "topic": "cost_effectiveness", "metric": "Manufacturer-sponsored 'economically justifiable price' for a 1-year (13-dose) donanemab course at $150,000/QALY threshold, health care system perspective", "value": 80538, "unit": "USD per 13-dose course", "year": 2024, "geography": "US-national", "population": "early symptomatic AD (TRAILBLAZER-ALZ 2 population)", "source_name": "Boustani M et al. (Eli Lilly). Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab. Neurol Ther 2024; doi:10.1007/s40120-024-00649-y (PMID 39292433)", "source_url": "https://doi.org/10.1007/s40120-024-00649-y", "notes": "MODELLED, MANUFACTURER-FUNDED (adapted ICER model). At $100,000/QALY: $44,691 (health system) / $55,419 (societal). At $150,000/QALY societal: $91,126. Conclusion favourable to manufacturer; contrast independent analyses." }, { "id": "econ-eisai-lecanemab-value-100k", "topic": "cost_effectiveness", "metric": "Manufacturer-sponsored annual value-based price of lecanemab at $100,000/QALY threshold, US payer perspective", "value": 18709, "unit": "USD per year", "year": 2023, "geography": "US-national", "population": "early AD (CLARITY AD-informed simulation)", "source_name": "Tahami Monfared AA et al. (Eisai). Estimated Societal Value of Lecanemab. Neurol Ther 2023; doi:10.1007/s40120-023-00460-1 (PMID 36929345)", "source_url": "https://doi.org/10.1007/s40120-023-00460-1", "notes": "MODELLED, MANUFACTURER-FUNDED. Range $18,709 ($100k/QALY) to $35,678 ($200k/QALY) payer; $19,710-$37,351 societal. QALY gain 0.61. Note even this analysis's $100k-$150k value price is below the $26,500 WAC at the $100k threshold." }, { "id": "econ-jiang-lecanemab-vs-aducanumab-2026", "topic": "cost_effectiveness", "metric": "ICER of lecanemab vs aducanumab (indirect comparison), US health system perspective", "value": 121678, "unit": "USD per QALY gained", "year": 2026, "geography": "US-national", "population": "early AD", "source_name": "Jiang X et al. Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease. Front Public Health 2026; doi:10.3389/fpubh.2026.1692508 (PMID 41694525)", "source_url": "https://doi.org/10.3389/fpubh.2026.1692508", "notes": "MODELLED (5-state Markov). Authors conclude at current list prices neither drug is cost-effective vs standard of care; comparison here is drug-vs-drug, not vs standard care." }, { "id": "econ-review-cea-count-2026", "topic": "cost_effectiveness", "metric": "Number of published cost-effectiveness analyses of aducanumab/lecanemab/donanemab meeting inclusion in a 2026 narrative review", "value": 16, "unit": "studies", "year": 2026, "geography": "global", "population": "early-onset/early-stage AD CEAs", "source_name": "Nguyen TT et al. Worth their weight in gray matter? Alzheimers Dement (N Y) 2026; doi:10.1002/trc2.70267 (PMID 42253439)", "source_url": "https://doi.org/10.1002/trc2.70267", "notes": "REVIEW. Aducanumab ICERs $127,461-$1,581,276/QALY (2026 USD), almost all above $100k-$150k thresholds. Lecanemab mixed: manufacturer-funded models below thresholds, independent models generally above. Single donanemab-vs-SoC analysis $214,760/QALY (2026 USD). No independent study found cost savings." }, { "id": "econ-review-donanemab-icer-2026usd", "topic": "cost_effectiveness", "metric": "Donanemab vs standard of care ICER from the single US analysis, inflated to 2026 USD by the review", "value": 214760, "unit": "USD per QALY gained (2026 USD)", "year": 2026, "geography": "US-national", "population": "early AD", "source_name": "Nguyen TT et al. Alzheimers Dement (N Y) 2026 (PMID 42253439)", "source_url": "https://doi.org/10.1002/trc2.70267", "notes": "MODELLED (review restatement of Ross et al. 2022 in 2026 dollars). Above $100k-$150k/QALY thresholds." }, { "id": "econ-sweden-lecanemab-ce-price-2025", "topic": "cost_effectiveness", "metric": "Cost-effective annual price of lecanemab in Sweden at willingness-to-pay of 1 million SEK per QALY (formal-care payer perspective)", "value": 33886, "unit": "SEK per year of treatment (2023 SEK)", "year": 2025, "geography": "country", "population": "early AD, Sweden (biomarker-confirmed)", "source_name": "Xia X et al. The Cost-Effective Price of Lecanemab for Patients with Early AD in Sweden. PharmacoEconomics 2025; doi:10.1007/s40273-025-01527-7 (PMID 40730714)", "source_url": "https://doi.org/10.1007/s40273-025-01527-7", "notes": "MODELLED (Swedish registers, 10-yr horizon, 3-yr max treatment). About US$3,200 at the paper's rate ($1 = 10.6 SEK). QALY gain 0.17; administration/monitoring net cost 87,146 SEK before drug cost. Conclusion: unlikely cost-effective at US list prices. Country: Sweden." }, { "id": "econ-australia-donanemab-icer-2026", "topic": "cost_effectiveness", "metric": "ICER of donanemab vs standard care in Australia, healthcare perspective", "value": 342424, "unit": "AUD per QALY gained", "year": 2026, "geography": "country", "population": "early symptomatic AD, APOE4 non-homozygous, Australia", "source_name": "Gao L, Watson R, Yassi N. Cost-Effectiveness of Donanemab for Early Alzheimer Disease in Australia. Med J Aust 2026; doi:10.5694/mja2.70186 (PMID 42015793)", "source_url": "https://doi.org/10.5694/mja2.70186", "notes": "MODELLED (Markov microsimulation). Societal $294,701/QALY. Exceeds 'frequently cited Australian willingness-to-pay thresholds' (specific threshold not given in abstract). Country: Australia." }, { "id": "econ-korea-lecanemab-icer-2025", "topic": "cost_effectiveness", "metric": "ICER of lecanemab + SoC vs SoC in South Korea, healthcare payer perspective", "value": 198171820, "unit": "KRW per QALY gained", "year": 2025, "geography": "country", "population": "early symptomatic AD, South Korea", "source_name": "Shin S, Kim M, Hong SH. Economic Evaluation of Lecanemab for Early Symptomatic AD in South Korea. Pharmacoecon Open 2025; doi:10.1007/s41669-025-00593-z (PMID 40685475)", "source_url": "https://doi.org/10.1007/s41669-025-00593-z", "notes": "MODELLED. Willingness-to-pay threshold 30 million KRW/QALY: NOT cost-effective (ICER ~6.6x threshold). Limited societal perspective 181,185,820 KRW/QALY. Lecanemab non-reimbursed in Korea per authors. Country: South Korea." }, { "id": "econ-brazil-lecanemab-icer-2025", "topic": "cost_effectiveness", "metric": "Cost per QALY gained, lecanemab vs acetylcholinesterase-inhibitor standard of care, Brazil healthcare perspective", "value": 2098225, "unit": "USD per QALY gained (2024 USD)", "year": 2025, "geography": "country", "population": "mild AD, Brazil", "source_name": "Price PU et al. Evaluating the Cost-Effectiveness of Pharmacological Therapy in AD in Brazil. Value Health Reg Issues 2025; doi:10.1016/j.vhri.2025.101130 (PMID 40435868)", "source_url": "https://doi.org/10.1016/j.vhri.2025.101130", "notes": "MODELLED (20-yr horizon). Donanemab vs lecanemab $1,460,400/QALY. Standard of care vs no drug $5,211/QALY. Threshold not stated in abstract. Country: Brazil." }, { "id": "econ-japan-lecanemab-icer-mci-2026", "topic": "cost_effectiveness", "metric": "ICER of lecanemab + SoC vs SoC for MCI due to AD in Japan, public healthcare + long-term care payer perspective (manufacturer-affiliated)", "value": 8500000, "unit": "JPY per QALY gained", "year": 2026, "geography": "country", "population": "MCI due to AD, Japan", "source_name": "Igarashi A et al. The social value of lecanemab for patients with early AD in Japan. J Alzheimers Dis 2026; doi:10.1177/13872877261447312 (PMID 42108615)", "source_url": "https://doi.org/10.1177/13872877261447312", "notes": "MODELLED; author list includes Eisai-affiliated authors (Tomita K et al.) - treat as manufacturer-affiliated. Mild AD dementia: JPY 7.9M/QALY. Includes caregiver utilities. Threshold not stated in abstract (Japan's cost-effectiveness evaluation reference is JPY 5M/QALY, not verified here). Country: Japan." }, { "id": "econ-europe-lecanemab-affordability-2023", "topic": "budget_impact", "metric": "Estimated annual treatment cost if all 5.4 million potentially eligible EU-27 patients received lecanemab priced as in the US", "value": 133, "unit": "billion EUR per year", "year": 2023, "geography": "global", "population": "EU-27 early AD population potentially eligible for lecanemab", "source_name": "Jönsson L et al. The affordability of lecanemab: an EADC-EC viewpoint. Lancet Reg Health Eur 2023; doi:10.1016/j.lanepe.2023.100657 (PMID 37251789)", "source_url": "https://doi.org/10.1016/j.lanepe.2023.100657", "notes": "MODELLED upper-bound scenario; would exceed half of total EU pharmaceutical expenditure. Geography: EU-27 (recorded as 'global' because schema lacks a multi-country region)." }, { "id": "econ-nice-decision-lecanemab-2025", "topic": "coverage_status", "metric": "NICE final draft guidance: lecanemab recommended for routine NHS use in England (1 = yes, 0 = no)", "value": 0, "unit": "binary", "year": 2025, "geography": "country", "population": "adults with MCI or mild dementia due to AD, APOE4 heterozygous or non-carriers, England", "source_name": "NICE news, 19 Jun 2025: Final draft guidance finds benefits of 2 Alzheimer's treatments remain too small to justify the additional costs to the NHS", "source_url": "https://www.nice.org.uk/news/articles/the-benefits-of-alzheimers-treatments-donanemab-and-lecanemab-remain-too-small-to-justify-the-additional-costs-says-nice-in-final-draft-guidance", "notes": "Zero is a real value here: NOT recommended (third negative decision). Reason: cost per QALY substantially exceeded NICE thresholds; NICE manual (PMG36) presents net health benefit at £25,000-£35,000 per QALY. NICE's own ICER figures are commercial-in-confidence. Appeal by Eisai received Oct 2025; appraisal GID-TA11220 still listed 'in progress' when fetched 22 Sep 2026. Country: UK (England/Wales)." }, { "id": "econ-nice-decision-donanemab-2025", "topic": "coverage_status", "metric": "NICE final draft guidance: donanemab recommended for routine NHS use in England (1 = yes, 0 = no)", "value": 0, "unit": "binary", "year": 2025, "geography": "country", "population": "adults with MCI or mild dementia due to AD, England", "source_name": "NICE news, 19 Jun 2025 (GID-TA11221)", "source_url": "https://www.nice.org.uk/news/articles/the-benefits-of-alzheimers-treatments-donanemab-and-lecanemab-remain-too-small-to-justify-the-additional-costs-says-nice-in-final-draft-guidance", "notes": "Zero is a real value: NOT recommended. Delay of mild-to-moderate progression 4-6 months judged too small for purchase + administration + MRI monitoring costs. Country: UK." }, { "id": "econ-nice-delay-months", "topic": "coverage_status", "metric": "Delay in progression from mild to moderate Alzheimer's cited by NICE for lecanemab and donanemab (upper bound of stated 4-6 months)", "value": 6, "unit": "months", "year": 2025, "geography": "country", "population": "MCI or mild dementia due to AD", "source_name": "NICE news, 19 Jun 2025", "source_url": "https://www.nice.org.uk/news/articles/the-benefits-of-alzheimers-treatments-donanemab-and-lecanemab-remain-too-small-to-justify-the-additional-costs-says-nice-in-final-draft-guidance", "notes": "NICE wording '4-6 months'; lower bound 4. Country: UK." }, { "id": "econ-cms-ncd-200-3-ced", "topic": "coverage_status", "metric": "CMS NCD 200.3: Medicare covers FDA-approved anti-amyloid mAbs under Coverage with Evidence Development (1 = covered with conditions)", "value": 1, "unit": "binary", "year": 2022, "geography": "US-national", "population": "Medicare beneficiaries with MCI due to AD or mild AD dementia with confirmed amyloid pathology", "source_name": "CMS Medicare Coverage Database, NCD 200.3 Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease", "source_url": "https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=375", "notes": "Effective 7 Apr 2022. Drugs approved on a surrogate endpoint (accelerated approval) covered only in RCTs under IND; drugs approved on clinical benefit (lecanemab traditional approval Jul 2023; donanemab Jul 2024) covered in CMS-approved prospective comparative studies, which may be registries. Use outside such studies is nationally non-covered. Amyloid PET in these studies also meets NCD 220.6.20 CED." }, { "id": "econ-va-coverage-lecanemab-2023", "topic": "coverage_status", "metric": "US Veterans Health Administration covers lecanemab for eligible veterans (1 = yes)", "value": 1, "unit": "binary", "year": 2023, "geography": "US-national", "population": "veterans with MCI or mild dementia due to AD meeting VHA criteria for use", "source_name": "Alzheimer's Association news, 13 Mar 2023: Association Applauds Coverage for Veterans Living with Alzheimer's", "source_url": "https://www.alz.org/news/2023/va-coverage-lecanemab", "notes": "VHA coverage announced March 2023 (two months after accelerated approval), with criteria for use beyond the FDA label. A July 2025 VA San Francisco story states VA covers both lecanemab and donanemab for eligible veterans (https://www.va.gov/san-francisco-health-care/stories/slowing-the-progression-offering-access-and-hope/)." }, { "id": "econ-japan-lecanemab-nhi-500mg-2023", "topic": "drug_price_list", "metric": "Japan National Health Insurance drug price for lecanemab 500 mg vial", "value": 114443, "unit": "JPY per vial", "year": 2023, "geography": "country", "population": "MCI and mild dementia due to AD, Japan", "source_name": "Eisai/Biogen press release, 12 Dec 2023: LEQEMBI to be launched in Japan on December 20", "source_url": "https://investors.biogen.com/news-releases/news-release-details/leqembir-intravenous-infusion-lecanemab-treatment-alzheimers", "notes": "REGULATED LIST PRICE (NHI). 200 mg vial 45,777 JPY. Implies about 229 JPY/mg. A 2026 Japanese study notes a scheduled 15% lecanemab price reduction effective 1 Nov 2025 (Makita K et al., PMID 42467046). Country: Japan." }, { "id": "econ-ltc-nursing-private-2025", "topic": "long_term_care_cost", "metric": "National median annual cost of a private room in a nursing home", "value": 129575, "unit": "USD per year", "year": 2025, "geography": "US-national", "population": "US nursing home residents (all causes)", "source_name": "CareScout (Genworth) Cost of Care Survey 2025", "source_url": "https://www.carescout.com/cost-of-care", "notes": "MEASURED (provider survey, Jul-Nov 2025). $355/day; $10,798/month. Up 1% from 2024. Not dementia-specific." }, { "id": "econ-ltc-nursing-semiprivate-2025", "topic": "long_term_care_cost", "metric": "National median annual cost of a semi-private room in a nursing home", "value": 114975, "unit": "USD per year", "year": 2025, "geography": "US-national", "population": "US nursing home residents (all causes)", "source_name": "CareScout (Genworth) Cost of Care Survey 2025", "source_url": "https://www.carescout.com/cost-of-care", "notes": "MEASURED. $315/day; $9,581/month; up 2% from 2024 ($9,277/month)." }, { "id": "econ-ltc-assisted-living-2025", "topic": "long_term_care_cost", "metric": "National median annual cost of an assisted living community", "value": 74400, "unit": "USD per year", "year": 2025, "geography": "US-national", "population": "US assisted living residents (all causes)", "source_name": "CareScout (Genworth) Cost of Care Survey 2025", "source_url": "https://www.carescout.com/cost-of-care", "notes": "MEASURED. $6,200/month, up 5% from $5,900 in 2024. Memory-care premium not broken out on this page." }, { "id": "econ-ltc-home-aide-hourly-2025", "topic": "long_term_care_cost", "metric": "National median hourly rate for a non-medical in-home caregiver (home health aide / homemaker)", "value": 35, "unit": "USD per hour", "year": 2025, "geography": "US-national", "population": "US home care (all causes)", "source_name": "CareScout (Genworth) Cost of Care Survey 2025", "source_url": "https://www.carescout.com/cost-of-care", "notes": "MEASURED; up 3% year over year. Skilled nursing in the home $90/hour. Facts and Figures 2026 cites the 2024 survey: home health aide $34/hr, $6,483/month; adult day services $100/day." }, { "id": "econ-ltc-adult-day-2024", "topic": "long_term_care_cost", "metric": "National median daily cost of adult day services", "value": 100, "unit": "USD per day", "year": 2024, "geography": "US-national", "population": "US adult day services users", "source_name": "Alzheimer's Association 2026 Facts and Figures, citing Genworth/CareScout 2024 Cost of Care Survey", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (survey). $104 in 2025 dollars; grew 5.6%/yr 2021-2024 before inflation adjustment." }, { "id": "econ-medicaid-ltss-total-2022", "topic": "long_term_care_cost", "metric": "Total Medicaid spending on long-term services and supports", "value": 200.4, "unit": "billion USD (2022 dollars)", "year": 2022, "geography": "US-national", "population": "all Medicaid LTSS users", "source_name": "Alzheimer's Association 2026 Facts and Figures (Long-Term Care section, citing ref. 954)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED (CMS expenditure data as cited). $212.4B in 2025 dollars. Home- and community-based services 65%, institutional 35%. HCBS share ranges 32% (Mississippi) to 84% (Oregon)." }, { "id": "econ-ltc-private-insurance-share-2023", "topic": "long_term_care_cost", "metric": "Share of US long-term services and supports costs paid by private insurance", "value": 9, "unit": "percent", "year": 2023, "geography": "US-national", "population": "all LTSS spending", "source_name": "Alzheimer's Association 2026 Facts and Figures, citing National Health Expenditure Accounts (ref. 952)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MEASURED. $49.1 billion. Same passage: Medicare covered 8% of LTSS; other private sources 7%." }, { "id": "econ-medicaid-ssi-resource-limit-2026", "topic": "medicaid_threshold_rules", "metric": "SSI resource (asset) standard for an individual, used as the countable-asset limit for Medicaid long-term care eligibility in SSI-criteria states", "value": 2000, "unit": "USD", "year": 2026, "geography": "US-national", "population": "Medicaid long-term care applicants (individual)", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026: Updated 2026 SSI and Spousal Impoverishment Standards", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY/REGULATORY (effective 1 Jan 2026). Couple $3,000. SSI federal benefit rate $994 individual / $1,491 couple. Income cap (300% FBR) $2,982/month. States using 209(b) or medically-needy rules may differ." }, { "id": "econ-medicaid-csra-max-2026", "topic": "medicaid_threshold_rules", "metric": "Community spouse resource allowance, federal maximum (assets the at-home spouse may keep when the other spouse enters Medicaid-covered nursing home care)", "value": 162660, "unit": "USD", "year": 2026, "geography": "US-national", "population": "married Medicaid institutional/HCBS applicants", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY (Section 1924 SSA), effective 1 Jan 2026. Minimum resource standard $32,532 (states choose within range)." }, { "id": "econ-medicaid-csra-min-2026", "topic": "medicaid_threshold_rules", "metric": "Community spouse resource allowance, federal minimum", "value": 32532, "unit": "USD", "year": 2026, "geography": "US-national", "population": "married Medicaid institutional/HCBS applicants", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY, effective 1 Jan 2026." }, { "id": "econ-medicaid-home-equity-min-2026", "topic": "medicaid_threshold_rules", "metric": "Home equity limit for Medicaid long-term care eligibility, federal minimum (state may raise up to the maximum)", "value": 752000, "unit": "USD", "year": 2026, "geography": "US-national", "population": "Medicaid long-term care applicants", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY, effective 1 Jan 2026. Maximum $1,130,000." }, { "id": "econ-medicaid-home-equity-max-2026", "topic": "medicaid_threshold_rules", "metric": "Home equity limit for Medicaid long-term care eligibility, federal maximum", "value": 1130000, "unit": "USD", "year": 2026, "geography": "US-national", "population": "Medicaid long-term care applicants", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY, effective 1 Jan 2026." }, { "id": "econ-medicaid-mmmna-max-2026", "topic": "medicaid_threshold_rules", "metric": "Maximum monthly maintenance needs allowance for the community spouse", "value": 4066.5, "unit": "USD per month", "year": 2026, "geography": "US-national", "population": "community spouses of Medicaid LTC beneficiaries", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY, effective 1 Jan 2026. Minimum MMMNA $2,705 (effective 1 Jul 2026; Alaska $3,381.25, Hawaii $3,111.25). Community spouse monthly housing allowance $811.50." }, { "id": "econ-medicaid-mmmna-min-2026", "topic": "medicaid_threshold_rules", "metric": "Minimum monthly maintenance needs allowance for the community spouse (48 states and DC)", "value": 2705, "unit": "USD per month", "year": 2026, "geography": "US-national", "population": "community spouses of Medicaid LTC beneficiaries", "source_name": "CMS CMCS Informational Bulletin, 27 Apr 2026", "source_url": "https://www.medicaid.gov/federal-policy-guidance/downloads/cib04272026.pdf", "notes": "STATUTORY, effective 1 Jul 2026." }, { "id": "econ-medicaid-spenddown-pna", "topic": "medicaid_threshold_rules", "metric": "Medicaid nursing home residents must contribute all monthly income except a personal needs allowance toward care (1 = rule applies)", "value": 1, "unit": "binary", "year": 2026, "geography": "US-national", "population": "Medicaid-covered nursing home residents", "source_name": "Alzheimer's Association 2026 Facts and Figures (Medicaid Costs section)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "Descriptive rule; personal needs allowance amount varies by state and is not given in the source. Beneficiaries above thresholds may spend down assets and income to qualify." }, { "id": "econ-global-vsl-burden-2019", "topic": "cost_projection", "metric": "Global value-of-statistical-life economic burden of Alzheimer's disease and related dementias", "value": 2.8, "unit": "trillion USD", "year": 2019, "geography": "global", "population": "people with ADRD worldwide", "source_name": "Nandi A et al. Global and regional projections of the economic burden of ADRD from 2019 to 2050: a value of statistical life approach. EClinicalMedicine 2022; doi:10.1016/j.eclinm.2022.101580 (PMID 35898316)", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101580", "notes": "MODELLED (value of lost DALYs; NOT a spending/cost-of-illness figure, so not comparable to Wimo's $1.3T)." }, { "id": "econ-global-vsl-burden-2050", "topic": "cost_projection", "metric": "Projected global value-of-statistical-life economic burden of ADRD in 2050", "value": 16.9, "unit": "trillion USD", "year": 2050, "geography": "global", "population": "people with ADRD worldwide", "source_name": "Nandi A et al. EClinicalMedicine 2022 (PMID 35898316)", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101580", "notes": "MODELLED/PROJECTED; 95% uncertainty bound $11.3T-$27.3T. 2030: $4.7T; 2040: $8.5T. LMICs would carry 65% of the 2050 burden vs 18% in 2019." }, { "id": "econ-global-health-spending-attrib-2019", "topic": "total_cost_of_care", "metric": "Global health-system spending attributable to dementia (direct health spending only)", "value": 263, "unit": "billion USD (2019)", "year": 2019, "geography": "global", "population": "people with dementia worldwide", "source_name": "Velandia PP et al. Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050. EClinicalMedicine 2022; doi:10.1016/j.eclinm.2022.101337 (PMID 35299657)", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101337", "notes": "MODELLED (GBD-based). 95% UI $199-333B. Total health spending on patients with dementia (all causes) $594B (95% UI $457-843B). Grew 4.5%/yr 2000-2019." }, { "id": "econ-global-health-spending-attrib-2050", "topic": "cost_projection", "metric": "Projected global health-system spending attributable to dementia in 2050, baseline scenario", "value": 1.6, "unit": "trillion USD (2019)", "year": 2050, "geography": "global", "population": "people with dementia worldwide", "source_name": "Velandia PP et al. EClinicalMedicine 2022 (PMID 35299657)", "source_url": "https://doi.org/10.1016/j.eclinm.2022.101337", "notes": "MODELLED/PROJECTED; 95% UI $0.9-2.6T; would be 11% (6-18%) of all health spending, up to 17% under alternative scenarios." }, { "id": "econ-stage-xu-inpatient-mild-dx", "topic": "per_person_cost_by_stage", "metric": "Traditional Medicare inpatient spending in the quarter of dementia diagnosis, persons diagnosed at MILD stage", "value": 8491, "unit": "USD per quarter", "year": 2016, "geography": "US-national", "population": "HRS respondents >70 with claims-based incident dementia diagnosis 2000-2016, severity modelled from ADAMS CDR", "source_name": "Xu S et al. Association of Dementia Severity at Diagnosis With Health Care Utilization and Costs Around the Time of Incident Diagnosis. Innov Aging 2025; doi:10.1093/geroni/igaf005 (PMID 40098605)", "source_url": "https://doi.org/10.1093/geroni/igaf005", "notes": "MEASURED claims costs with MODELLED severity assignment. Rose from $3,192 the quarter before (+166%). Outpatient spending in quarter of diagnosis, mild stage: $4,498. Dollar year and full-year totals not in extracted text." }, { "id": "econ-stage-xu-inpatient-moderate-dx", "topic": "per_person_cost_by_stage", "metric": "Traditional Medicare inpatient spending in the quarter of dementia diagnosis, persons diagnosed at MODERATE stage", "value": 8831, "unit": "USD per quarter", "year": 2016, "geography": "US-national", "population": "HRS respondents >70 with incident dementia diagnosis 2000-2016", "source_name": "Xu S et al. Innov Aging 2025 (PMID 40098605)", "source_url": "https://doi.org/10.1093/geroni/igaf005", "notes": "MEASURED claims / MODELLED severity. From $2,534 the quarter before (+248%). Outpatient: $2,028 to $3,979 (+96%)." }, { "id": "econ-stage-xu-inpatient-severe-dx", "topic": "per_person_cost_by_stage", "metric": "Traditional Medicare inpatient spending in the quarter of dementia diagnosis, persons diagnosed at SEVERE stage", "value": 8169, "unit": "USD per quarter", "year": 2016, "geography": "US-national", "population": "HRS respondents >70 with incident dementia diagnosis 2000-2016", "source_name": "Xu S et al. Innov Aging 2025 (PMID 40098605)", "source_url": "https://doi.org/10.1093/geroni/igaf005", "notes": "MEASURED claims / MODELLED severity. From $2,645 the quarter before (+209%). Outpatient: $1,737 to $3,454 (+99%). Median wealth (2016 dollars) at diagnosis: mild $288,731, moderate $114,410, severe $56,852." }, { "id": "econ-unpaid-value-alabama-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Alabama", "value": 6391.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Alabama (222 thousand caregivers; 396 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-montana-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Montana", "value": 652.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Montana (18 thousand caregivers; 26 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-alaska-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Alaska", "value": 929.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Alaska (25 thousand caregivers; 40 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-nebraska-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Nebraska", "value": 1617.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Nebraska (42 thousand caregivers; 63 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-arizona-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Arizona", "value": 9700.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Arizona (242 thousand caregivers; 379 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-nevada-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Nevada", "value": 5651.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Nevada (137 thousand caregivers; 226 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-arkansas-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Arkansas", "value": 4957.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Arkansas (175 thousand caregivers; 268 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-new-hampshire-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, New Hampshire", "value": 1518.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, New Hampshire (57 thousand caregivers; 66 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-california-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, California", "value": 53229.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, California (1403 thousand caregivers; 1904 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-new-jersey-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, New Jersey", "value": 13561.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, New Jersey (283 thousand caregivers; 512 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-colorado-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Colorado", "value": 9613.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Colorado (211 thousand caregivers; 336 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-new-mexico-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, New Mexico", "value": 2387.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, New Mexico (68 thousand caregivers; 119 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-connecticut-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Connecticut", "value": 6255.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Connecticut (197 thousand caregivers; 241 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-new-york-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, New York", "value": 33771.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, New York (776 thousand caregivers; 1299 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-delaware-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Delaware", "value": 1649.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Delaware (37 thousand caregivers; 67 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-north-carolina-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, North Carolina", "value": 8300.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, North Carolina (338 thousand caregivers; 446 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-district-of-columbia-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, District of Columbia", "value": 405.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, District of Columbia (15 thousand caregivers; 15 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-north-dakota-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, North Dakota", "value": 609.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, North Dakota (19 thousand caregivers; 26 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-florida-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Florida", "value": 30319.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Florida (877 thousand caregivers; 1378 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-ohio-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Ohio", "value": 15506.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Ohio (490 thousand caregivers; 705 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-georgia-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Georgia", "value": 14303.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Georgia (391 thousand caregivers; 789 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-oklahoma-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Oklahoma", "value": 4776.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Oklahoma (135 thousand caregivers; 226 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-hawaii-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Hawaii", "value": 3275.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Hawaii (62 thousand caregivers; 111 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-oregon-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Oregon", "value": 8001.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Oregon (188 thousand caregivers; 291 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-idaho-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Idaho", "value": 2432.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Idaho (74 thousand caregivers; 118 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-pennsylvania-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Pennsylvania", "value": 17213.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Pennsylvania (472 thousand caregivers; 835 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-illinois-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Illinois", "value": 16690.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Illinois (465 thousand caregivers; 668 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-rhode-island-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Rhode Island", "value": 1525.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Rhode Island (37 thousand caregivers; 53 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-indiana-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Indiana", "value": 6622.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Indiana (221 thousand caregivers; 329 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-south-carolina-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, South Carolina", "value": 7029.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, South Carolina (229 thousand caregivers; 377 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-iowa-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Iowa", "value": 2730.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Iowa (80 thousand caregivers; 118 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-south-dakota-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, South Dakota", "value": 910.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, South Dakota (29 thousand caregivers; 33 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-kansas-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Kansas", "value": 3377.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Kansas (141 thousand caregivers; 172 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-tennessee-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Tennessee", "value": 13121.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Tennessee (393 thousand caregivers; 686 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-kentucky-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Kentucky", "value": 6654.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Kentucky (190 thousand caregivers; 323 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-texas-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Texas", "value": 35637.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Texas (1287 thousand caregivers; 1913 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-louisiana-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Louisiana", "value": 5353.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Louisiana (221 thousand caregivers; 366 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-utah-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Utah", "value": 3383.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Utah (118 thousand caregivers; 150 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-maine-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Maine", "value": 2993.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Maine (66 thousand caregivers; 103 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-vermont-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Vermont", "value": 836.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Vermont (20 thousand caregivers; 29 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-maryland-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Maryland", "value": 7347.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Maryland (260 thousand caregivers; 294 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-virginia-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Virginia", "value": 12835.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Virginia (333 thousand caregivers; 561 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-massachusetts-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Massachusetts", "value": 6723.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Massachusetts (220 thousand caregivers; 254 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-washington-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Washington", "value": 11632.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Washington (257 thousand caregivers; 393 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-michigan-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Michigan", "value": 16280.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Michigan (422 thousand caregivers; 682 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-west-virginia-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, West Virginia", "value": 2181.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, West Virginia (65 thousand caregivers; 116 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-minnesota-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Minnesota", "value": 6280.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Minnesota (168 thousand caregivers; 231 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-wisconsin-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Wisconsin", "value": 7292.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Wisconsin (206 thousand caregivers; 322 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-mississippi-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Mississippi", "value": 2701.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Mississippi (109 thousand caregivers; 168 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-wyoming-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Wyoming", "value": 601.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Wyoming (19 thousand caregivers; 30 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-unpaid-value-missouri-2025", "topic": "unpaid_caregiving", "metric": "Economic value of unpaid dementia caregiving, Missouri", "value": 8558.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "unpaid caregivers of people with Alzheimer's or other dementias, Missouri (227 thousand caregivers; 357 million hours)", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 10", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED (BRFSS 2016-2024 caregiver data x state hourly value = average of state minimum wage and median home health aide cost). State totals do not sum to US total due to rounding." }, { "id": "econ-medicaid-spend-alabama-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Alabama", "value": 1277.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Alabama", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-montana-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Montana", "value": 230.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Montana", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-alaska-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Alaska", "value": 125.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Alaska", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-nebraska-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Nebraska", "value": 465.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Nebraska", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-arizona-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Arizona", "value": 617.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Arizona", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-nevada-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Nevada", "value": 314.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Nevada", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-arkansas-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Arkansas", "value": 514.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Arkansas", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-new-hampshire-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, New Hampshire", "value": 380.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, New Hampshire", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-california-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, California", "value": 5931.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, California", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-new-jersey-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, New Jersey", "value": 2962.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, New Jersey", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-colorado-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Colorado", "value": 893.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Colorado", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-new-mexico-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, New Mexico", "value": 316.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, New Mexico", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-connecticut-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Connecticut", "value": 1344.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Connecticut", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-new-york-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, New York", "value": 7144.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, New York", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-delaware-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Delaware", "value": 354.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Delaware", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-north-carolina-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, North Carolina", "value": 1844.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, North Carolina", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-district-of-columbia-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, District of Columbia", "value": 153.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, District of Columbia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-north-dakota-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, North Dakota", "value": 244.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, North Dakota", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-florida-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Florida", "value": 3912.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Florida", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-ohio-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Ohio", "value": 3330.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Ohio", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-georgia-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Georgia", "value": 1806.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Georgia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-oklahoma-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Oklahoma", "value": 692.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Oklahoma", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-hawaii-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Hawaii", "value": 323.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Hawaii", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-oregon-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Oregon", "value": 359.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Oregon", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-idaho-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Idaho", "value": 222.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Idaho", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-pennsylvania-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Pennsylvania", "value": 4565.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Pennsylvania", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-illinois-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Illinois", "value": 2492.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Illinois", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-rhode-island-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Rhode Island", "value": 640.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Rhode Island", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-indiana-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Indiana", "value": 1397.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Indiana", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-south-carolina-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, South Carolina", "value": 927.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, South Carolina", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-iowa-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Iowa", "value": 897.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Iowa", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-south-dakota-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, South Dakota", "value": 240.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, South Dakota", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-kansas-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Kansas", "value": 615.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Kansas", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-tennessee-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Tennessee", "value": 1560.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Tennessee", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-kentucky-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Kentucky", "value": 1075.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Kentucky", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-texas-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Texas", "value": 4474.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Texas", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-louisiana-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Louisiana", "value": 1058.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Louisiana", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-utah-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Utah", "value": 267.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Utah", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-maine-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Maine", "value": 311.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Maine", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-vermont-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Vermont", "value": 166.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Vermont", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-maryland-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Maryland", "value": 1739.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Maryland", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-virginia-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Virginia", "value": 1435.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Virginia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-massachusetts-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Massachusetts", "value": 2301.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Massachusetts", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-washington-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Washington", "value": 780.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Washington", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-michigan-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Michigan", "value": 1969.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Michigan", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-west-virginia-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, West Virginia", "value": 590.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, West Virginia", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-minnesota-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Minnesota", "value": 1231.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Minnesota", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-wisconsin-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Wisconsin", "value": 1047.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Wisconsin", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-mississippi-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Mississippi", "value": 826.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Mississippi", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-wyoming-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Wyoming", "value": 126.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Wyoming", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-spend-missouri-2025", "topic": "payer_share", "metric": "Total Medicaid payments for people age 65+ with Alzheimer's or other dementias, Missouri", "value": 1288.0, "unit": "million USD (2025 dollars)", "year": 2025, "geography": "US-state", "population": "Medicaid beneficiaries age 65+ with dementia, Missouri", "source_name": "Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures, Table 22 (Lewin Model)", "source_url": "https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf", "notes": "MODELLED small-area estimate (Lewin Model); do not treat as measured state expenditure." }, { "id": "econ-medicaid-lookback-months", "topic": "medicaid_threshold_rules", "metric": "Medicaid asset-transfer look-back period for institutional/long-term care eligibility (transfers for less than fair market value on or after 8 Feb 2006)", "value": 60, "unit": "months", "year": 2023, "geography": "US-national", "population": "Medicaid long-term care applicants", "source_name": "42 U.S.C. 1396p(c)(1)(B)(i), U.S. Code 2023 edition (govinfo)", "source_url": "https://www.govinfo.gov/content/pkg/USCODE-2023-title42/html/USCODE-2023-title42-chap7-subchapXIX-sec1396p.htm", "notes": "STATUTORY. 36 months for other transfers before that date. Transfers within the look-back trigger a penalty period of ineligibility computed from the transferred amount (subparagraph E)." } ]